Flaviviruses consist of significant human pathogens responsible for hundreds of millions of
infections each year. Their antigenic relationships generate immune responses that are …

The unprecedented 2015–2016 Zika outbreak in the Americas sparked global concern and
drove the rapid deployment of vaccine and therapeutic countermeasures against this re …

ABSTRACT A comprehensive study of the B cell response against SARS-CoV-2 could be
significant for understanding the immune response and developing therapeutical antibodies …

Congenital Zika virus (ZIKV) infection results in neurodevelopmental deficits in up to 14% of
infants born to ZIKV-infected mothers. Neutralizing antibodies are a critical component of …

Zika virus (ZIKV) is a flavivirus primarily transmitted by Aedes species mosquitoes, first
discovered in Africa in 1947, that disseminated through Southeast Asia and the Pacific …

Serum titers of SARS-CoV-2-neutralizing antibodies (nAbs) correlate well with protection
from symptomatic COVID-19 but decay rapidly in the months following vaccination or …

Introduction Zika virus (ZIKV) infection during pregnancy results in a spectrum of birth
defects and neurodevelopmental deficits in prenatally exposed infants, with no clear …

Hundreds of millions of people worldwide are affected by viral infections each year, and yet,
several of them neither have vaccines nor effective treatment during and post-infection. This …

Acute febrile illness is a common problem managed by clinicians and health systems
globally, particularly in the Tropics. In many regions, malaria is a leading and potentially …

Objectives Aedes-borne viruses (ABV) affect humans on every inhabited continent and
frequently cause epidemics. Recent epidemics of chikungunya and Zika viruses (ZIKV) …